MEAGAN HINCH: Open Payments
NPI 1477901379 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$384 in 20 payments from 9 companies in 2025. Trend: 2023 $415 · 2024 $392 · 2025 $384
Food & beverage: $384
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $134 |
| PFIZER INC. | 3 | $66 |
| Novo Nordisk Inc | 2 | $37 |
| Boston Scientific Corporation | 1 | $35 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| Kestra Medical Technology Services, Inc. | 1 | $28 |
| SCPHARMACEUTICALS INC. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: LEQVIO, ELIQUIS, WATCHMAN, Assure WCD, FUROSCIX, Wegovy, Ozempic, CAMZYOS.
Industry payments across LA — which companies pay providers there.
